Revenue from operations₹178.86 Cr
VENUSREM · What Changed
What Changed at
Venus Remedies Limited?
See reported financial changes and material NSE disclosures for Venus Remedies Limited.
My CompaniesSaved on this device. No account needed.
Follow a company to build your personal change feed.
Latest company changes
Venus Remedies Limited
Start with what changed, then open the supporting financial and operating detail only when you need it.
VENUSREM · Consolidated
Venus Remedies Limited
Latest reported period
Latest reported changes
What Actually Changed
Worth reviewingNeutral / mixedNSE disclosure · 20 Aug 2026ManagementThe company appointed Dr. Gurminder Singh Bedi as Non- Executive Independent Director of the company w.e.f. May 26, 2026.
+
Worth reviewingNeutral / mixedNSE disclosure · 20 Aug 2026ManagementThe company appointed Dr. (Mrs.) Manu Chaudhary as Joint Managing Director of the company w.e.f. October 01, 2026.
+
Worth reviewingNeutral / mixedNSE disclosure · 20 Aug 2026ManagementThe company appointed Dr. (Mrs.) Savita Gupta as Non- Executive Independent Director of the company w.e.f. December 30, 2026.
+
Worth reviewingNeutral / mixedNSE disclosure · 20 Aug 2026ManagementThe company appointed Mr. Saransh Chaudhary as Executive Director of the company w.e.f. May 26, 2026.
+
Worth reviewingNeutral / mixedNSE disclosure · 7 Aug 2026Corporate ActionThe company disclosed dividend - Rs 10 Per Share.
+
Financial snapshot
Latest Reported Financials
Available reported figures from the latest period.
Total income₹181.48 Cr
Profit after tax₹22.97 Cr
EPS₹17.18
Profit before tax₹30.04 Cr
Supporting financial context
Margins and Supporting Figures
Only reported or directly calculated figures that are available for this company.
PAT margin12.84%
Profit before tax₹30.04 Cr
Finance cost₹0.00 Cr
Depreciation₹6.77 Cr
Tax₹7.07 Cr
Other income₹2.62 Cr
Today
Loading today’s changes…Today on Nivata
— meaningful changes— companies
Checking the latest tracked company developments…